Article
Effects of the mTOR and AKT genes polymorphisms on systemic lupus erythematosus risk.
Molecular biology reports - 1 May 2020
Saravani Mohsen, Shahraki-Ghadimi Hossein, Maruei-Milan Rostam, Mehrabani Mehrnaz, Mirzamohammadi Solmaz, Nematollahi Mohammad Hadi
Abstract excerpt
The systemic lupus erythematosus (SLE) is an autoimmune disease, leading to inflammatory response and systemic consequences. The mammalian target of rapamycin (mTOR) is a therapeutic target for autoimmune diseases like SLE. The aim of this study was to evaluate the effects of the mTOR rs2295080 and rs2536 polymorphisms and AKT1 rs2494732 gene polymorphism on SLE development. 2 ml of peripheral blood was collected...
Read the complete abstract on PubMed